Comparative effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features.

R. Klorman,J. T. Brumaghim,L. Salzman,J. Strauss,A. Borgstedt,M. Mcbride,S. Loeb
Psychopharmacology Bulletin
Abstract:This study compared the impact of methylphenidate on patients with attention-deficit hyperactivity disorder (ADHD) with and without aggressive/noncompliant features. Methylphenidate (0.3 nig/Kg twice daily) and placebo were administered double-blind for 14 days each to 24 ADHD/nonaggressive, 19 ADHD/aggressive, and 20 borderline ADHD children. In general, the following benefits of methylphenidate were comparable for ADHD subgroups: (a) behavioral improvement observed by parents and teachers, (b) increases in accuracy and speed on two versions of the Continuous Performance Test (CPT), and (c) enlargement of the P3b wave of event-related potentials in the more difficult of the two CPTs. Thus, stimulant therapy had comparable benefits for ADHD patients with and without aggression/noncompliance.
What problem does this paper attempt to address?